Slow-cycling therapy-resistant cancer cells
Nathan Moore1, JeanMarie Houghton, Stephen Lyle
1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Stem Cells and Development
|October 7, 2011
Summary
Scientists identified slow-cycling tumor cells, resistant to chemotherapy, using carboxyfluorescein diacetate, succinimidyl ester (CFSE). These cells drive tumor regrowth and could be targets for new cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Tumor recurrence post-chemotherapy significantly impacts patient outcomes.
- Therapy-resistant cancer cells are believed to drive tumor regrowth.
- Characterizing these resistant cells is crucial for developing effective targeted therapies.
Purpose of the Study:
- To identify and characterize therapy-resistant tumor cells.
- To investigate the role of slow-cycling cells in chemotherapy resistance.
- To develop novel methods for isolating and analyzing these cells.
Main Methods:
- Utilized carboxyfluorescein diacetate, succinimidyl ester (CFSE) as a proliferation marker.
- Identified label-retaining, slow-cycling tumor cells in vitro and in vivo.
- Employed live cell sorting to isolate slow-cycling tumor cells.
Main Results:
- Discovered a population of slow-cycling, label-retaining tumor cells.
- Demonstrated that these cells possess enhanced chemoresistance.
- Confirmed their ability to reenter the cell cycle and drive tumor regrowth.
- Validated their tumorigenic potential after isolation.
Conclusions:
- Slow-cycling, label-retaining cells are a key component of chemotherapy resistance.
- Carboxyfluorescein diacetate, succinimidyl ester (CFSE) enables isolation and characterization of these resistant cells.
- Targeting these cells may lead to more durable cancer treatment responses.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...